secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunovant, Inc. (IMVT)
CIK:        0001764013
Form:       8-K
Filed at:   2023-09-28T23:59:59+00:00
Accession:  0001193125-23-245815
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunovant Prices $280M Public Offering; Roivant Commits $170M Private Placement
--------------------------------------------------------------------------------

- Public offering of 7,370,000 shares at $38.00/share; gross proceeds ~$280.1M.
- Roivant Sciences, majority stockholder, to purchase 4,473,684 shares at same price; proceeds ~$170M.
- Combined gross proceeds ~$450M before expenses; expected closing October 2, 2023.
- Underwriters granted 30-day option to buy up to 1,105,500 additional shares.
- Private placement exempt from registration under Section 4(a)(2) of Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1764013/000119312523245815/0001193125-23-245815-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1764013/000119312523245815/d555888d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-245815

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer